• About us
• Contact

Advertisement

Organisation › Details

PhenomeX Inc. (CELL)

PhenomeX is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology that will advance human health. We enable scientists to reveal the most complete insights on cell function and obtain a full view of the behavior of each cell. Our unique suite of proven high-throughput tools and services offer unparalleled resolution and speed, accelerating the insights that are key to advancing discoveries that can profoundly improve the prevention and treatment of disease. Our award-winning platforms are used by researchers across the globe, including those at the top 15 global pharmaceutical companies and approximately 85% of leading U.S. comprehensive cancer centers. *

 

	Start	2023-03-20 merged + renamed
	Group	Bruker (Group)
	Predecessor	Berkeley Lights Inc. (Nasdaq: BLI)
	Industry	Beacon® optofluidic platform
	Industry 2	IsoLight detection system
	Person	Kadia, Siddhartha C. (PhenomeX 202308 CEO before Berkely Lights + EAG Laboratories + Life Technologies)
	Region	Emeryville, CA
	Country	United States (USA)
	City	n. a.
		Address record changed: 2023-08-22
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	95,000,000 (revenues, annual (pro forma combined) 2022-12-31)
		* Document for »About Section«: Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA.
		Record changed: 2026-05-02

Advertisement

More documents for Bruker (Group)

• [1] Bruker Corporation. (8/11/26). "Press Release: Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories". Boston, MA....
• [2] Bruker Corporation. (8/10/26). "Press Release: Bruker Reports Second Quarter 2026 Financial Results". Billerica, MA....
• [3] Bruker Corporation. (8/10/26). "Press Release: Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development". Leiden....
• [4] Bruker Corporation. (7/15/26). "Press Release: Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER Platform for Pathogenic Microorganisms in Blood". Bremen....
• [5] Bruker Corporation. (6/4/26). "Press Release: Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026". Washington, DC....
• [6] Bruker Corporation. (6/2/26). "Press Release: Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry". San Diego, CA....
• [7] Bruker Corporation. (5/26/26). "Press Release: Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI". Billerica, MA....
• [8] Bruker Corporation. (5/26/26). "Press Release: Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – All to Enable Deep...
• [9] Bruker Corporation. (5/6/26). "Press Release: Bruker Reports First Quarter 2026 Financial Results". Billerica, MA....
• [10] Bruker Corporation. (4/17/26). "Press Release: Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026". Munich....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.